CVE-2012-1004

Description

Multiple cross-site scripting (XSS) vulnerabilities in UI/Register.pm in Foswiki before 1.1.5 allow remote authenticated users with CHANGE privileges to inject arbitrary web script or HTML via the (1) text, (2) FirstName, (3) LastName, (4) OrganisationName, (5) OrganisationUrl, (6) Profession, (7) Country, (8) State, (9) Address, (10) Location, (11) Telephone, (12) VoIP, (13) InstantMessagingIM, (14) Email, (15) HomePage, or (16) Comment parameter. NOTE: some of these details are obtained from third party information.

Category

2.1
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.26%
Vendor Advisory foswiki.org Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://st2tea.blogspot.com/2012/02/foswiki-cross-site-scripting.html
http://secunia.com/advisories/47849 third party advisory vendor advisory
http://foswiki.org/Support/SecurityAlert-CVE-2012-1004 vendor advisory
http://foswiki.org/Tasks/Item11501
http://foswiki.org/Tasks/Item11498

Frequently Asked Questions

What is the severity of CVE-2012-1004?
CVE-2012-1004 has been scored as a low severity vulnerability.
How to fix CVE-2012-1004?
To fix CVE-2012-1004, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-1004 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2012-1004 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.